Newly approved injection Taltz (ixekizumab) will offer another treatment option for plaque psoriasis.
The American Academy of Dermatology estimates that nearly 7.5 million people in the United States suffer from psoriasis. It can cause itchy, dry, scaly patches of skin, and comes along with many complications and other diseases, including arthritis, depression, obesity, diabetes, and high blood pressure.
Is there anything unique about Taltz, compared to other psoriasis meds?
No. Taltz is a once-monthly dosing option (after a few more frequent initial doses to get you started). Cosentyx (secukinumab), another monthly psoriasis medication, is in the same class of drugs as Taltz, and also treats moderate-to-severe plaque psoriasis.
How does Taltz work?
The active ingredient in Taltz works deep inside of your cells, disrupting certain signals. This blocks a certain protein that causes inflammation.
How is Taltz used?
Once you’ve gone through the initial dosing steps, the recommended dose is a single injection every four weeks.
To start with though, you’ll use two injections at week 0 (your first dose), followed by a single injection at weeks 2, 4, 6, 8, 10, and 12.
What are the side effects of Taltz?
The most common side effects associated with Taltz are upper respiratory tract infections (common cold or sinus infections), injection site reactions, and fungal infections.
Yes. There are several medications that are similar to Taltz, but that work slightly different to treat moderate-to-severe psoriasis:
- Injectable (self-administered, you can use these at home)
- Oral tablet (also self-administered)
- Otezla (apremilast)
- Infusion (healthcare professional administered, your doctor must give you the injection)
- Remicade (infliximab)
Want more information on Taltz?
See the announcement from the FDA here.